The purpose of this study was to determine the expression of genes encoding various sarcoplasmic reticulum components that are functionally coupled with calcium release, uptake, and storage function during cardiac hypertrophy induced by thyroid hormone. Hyperthyroidism was induced in two groups of rabbits by the injection of 200 gg/kg L-thyroxine (T4) daily for 4 days (T4-4-day group) and 8 days (T4-8-day group). Hypothyroidism was induced in another group of rabbits by adding 0.8 mg/ml propylthiouracil to the drinking water for 4 weeks. The relative expression level of mRNA encoding different sarcoplasmic reticulum proteins was determined by RNA slot blot and Northern blot analysis. In hyperthyroid hearts, the steady-state level of cardiac ryanodine receptor mRNA and sarcoplasmic reticulum cardiac/slow-twitch Ca2'-ATPase mRNA were both increased to 147% (T4-4-day group) and 186% (T4-8-day group) of control, respectively, but decreased to 71% and 75%, respectively, in hypothyroid ventricles. The mRNA level for phospholamban was decreased in both hyperthyroidism (T4-8-day group, 72%) and hypothyroidism (77%) in these hearts. On the other hand, calsequestrin mRNA levels did not change in hyperthyroid and hypothyroid ventricles. In accord with the changes in Ca24-ATPase mRNA levels, the Ca2+-ATPase protein was increased to 199%o (T4-8-day group) in hyperthyroid ventricles and decreased to 86% of control in hypothyroid ventricles. The expression levels of ryanodine receptor, Ca24-ATPase, phospholamban, and calsequestrin mRNAs were similarly altered in skeletal muscle tissues from hyperthyroid and hypothyroid rabbits. These results indicate that the mRNA levels of sarcoplasmic reticulum proteins responsible for calcium release and calcium uptake are coordinately regulated in response to changes in thyroid hormone level in both heart and skeletal muscle. These changes in mRNA level should lead to changes in protein levels and thus to altered calcium release and uptake in the chronic stages of hyperthyroidism and hypothyroidism. (Circulation Research 1991;69:266-276) T hyroid hormone-induced cardiac hypertrophy is a well-defined experimental model used to investigate mechanisms altering cardiac function.1,2 Cardiac hypertrophy after thyroxine administration to experimental animals is associated with an increased rate of tension development and an From the
T hyroid hormone-induced cardiac hypertrophy is a well-defined experimental model used to investigate mechanisms altering cardiac function.1,2 Cardiac hypertrophy after thyroxine administration to experimental animals is associated with an increased rate of tension development and an without an alteration in the peak level of free cytoplasmic calcium during contraction in thyrotoxic hearts.15"6 These alterations of sarcoplasmic reticulum function are thought to play an important role in determining the contractile properties of the hypertrophied myocardium. The molecular basis for altered sarcoplasmic reticulum function, however, remains to be determined.
In recent years, the major sarcoplasmic reticulum proteins controlling calcium release, reuptake, and storage have been isolated, and their primary structures have been determined. 17 The calcium release channel (ryanodine receptor) has been identified as a tetramer made up of subunits of Mr=565,000 Da. [18] [19] [20] [21] [22] [23] Two distinct isoforms of the ryanodine receptor have been identified in cardiac and skeletal muscle. [20] [21] [22] [23] The cardiac isoform is expressed in heart and brain, whereas the skeletal muscle isoform is expressed in fast-and slow-twitch skeletal muscle. 23, 24 Similarly, Ca24-ATPase, the major protein controlling calcium uptake, has been well characterized in cardiac and skeletal muscle.17 Recent molecular cloning analysis has identified at least five distinct isoforms of the Ca2+-ATPase: adult fast-twitch muscle isoform (SERCA1a),25 its alternatively spliced neonatal isoform (SERCA1b),26 cardiac/slow-twitch muscle isoform (SERCA2a),13'27 its alternatively spliced smooth/nonmuscle isoform (SERCA2b),28,29 and an isoform found in a broad variety of muscle and nonmuscle tissues (SERCA3).30 In addition to the calcium release channel and Ca2+-ATPase, phospholamban and calsequestrin have an important role in sarcoplasmic reticulum function. The calcium pumping action of Ca2+-ATPase has been shown to be inhibited by phospholamban. [31] [32] [33] There are no isoforms for phospholamban, and the same protein is expressed in cardiac and slow-twitch muscle. 34, 35 The calcium exchanges between the cytosol and sarcoplasmic reticulum are influenced by calcium binding proteins located within the sarcoplasmic reticulum membranes. Calsequestrin is located within the lumen of sarcoplasmic reticulum and acts as a calcium buffer or store.36-38 Two isoforms, a cardiac muscle isoform39 and a fast-twitch muscle isoform,4O1 have been identified.
The present study was undertaken to examine the mechanisms altering sarcoplasmic reticulum function during cardiac hypertrophy, with the following objectives: 1) to determine the effect of thyroid hormone on the expression of mRNA encoding individual sarcoplasmic reticulum proteins that are responsible for calcium release, uptake, and storage in rabbit hearts, 2) to determine whether the expression of sarcoplasmic reticulum proteins controlling both calcium release and calcium uptake are regulated in a coordinate manner during cardiac hypertrophy, and 3) to determine whether thyroid hormone affects the expression of sarcoplasmic reticulum proteins to the same degree in skeletal muscle, since skeletal muscle is not subjected to the increased hemodynamic load imposed on the heart secondary to hyperthyroidism.
Materials and Methods Animal Models
New Zealand White male rabbits were obtained commercially (Charles River Laboratories, Inc., Montreal, Canada) and maintained on ordinary rabbit chow. Thyrotoxic cardiac hypertrophy was produced in 16-week-old rabbits by injecting L-thyroxine (T4) intramuscularly at 200 pg/kg body wt for 4 days (n=4) or 8 days (n=4).1"13 Age-matched untreated rabbits (n =4) were used as controls. Hypothyroidism was induced in 12-week-old rabbits by adding 0.8 mg/ml of propylthiouracil (PTU) to the drinking water for 4 weeks (n =4).42 All rabbits were placed under sodium pentobarbital anesthesia (30 mg/kg), and the heart and other tissues were quickly removed. The atria and ventricles were rinsed in cold physiological saline, blotted onto sterile paper towels, weighed, and frozen in liquid nitrogen. Other tissues were immediately immersed in liquid nitrogen.
Isolation of RNA
Total cellular RNA was isolated using the guanidine thiocyanate method. 43 The final RNA pellet was resuspended in a solution containing 10 mM Tris (pH 7.5) and 1 mM EDTA (pH 7.5) and stored at -70°C.
Probes
The following cDNA and genomic probes were used for Northern blot and RNA slot blot analyses: 1) For the cardiac ryanodine receptor, a 2.25-kb cDNA fragment corresponding to amino acids 2662-3413 of rabbit cardiac muscle ryanodine receptor was used. 23 2) For the skeletal ryanodine receptor, a 3-kb cDNA fragment corresponding to amino acids 2846-3873 of rabbit skeletal muscle ryanodine receptor was used. 22 3) For Ca2+-ATPase, a 1.7-kb cDNA fragment containing the protein coding region and the 3' untranslated region of rabbit cardiac/slow-twitch muscle Ca2 -ATPase (BamHI-3' end) was used.27 This probe cross-hybridizes to fast-twitch and smooth muscle/nonmuscle Ca24-ATPase mRNA isoforms. 26 (20, 10, 5 , and 2.5 ,ug) of samples were loaded onto the nitrocellulose filter of a slot blot apparatus (Schleicher & Schuell). The same amount of tRNA was also loaded to detect nonspecific binding of probes. The nitrocellulose filter was hybridized with "2P-labeled cDNA probes (ryanodine receptors and GAPDH) as described for Northern blot analysis. Autoradiograms in which the densities of bands were linearly increased with loading of 2.5, 5, 10, and 20 ,ug RNA were quantitated by densitometer scanning. The optical density measured using the ryanodine receptor probe was divided by the optical density obtained using the GAPDH probe. The relative expression level of ryanodine receptor mRNA over GAPDH mRNA in each sample was calculated as a percentage of the mean value observed for the control group.
Isolation of Crude Sarcoplasmic Reticulum
Crude sarcoplasmic reticulum was isolated using a modified method of Jones et al. 45 14,000g (maximum) for 20 minutes, and the resulting supernatant fraction was sedimented at 100,000g (maximum) for 45 minutes. The pellet was resuspended in 3 ml of 150 mM KCI and 1 mM HEPES (pH 7.1) and recentrifuged at 100,000g
(maximum) for 45 minutes. The pellet was resuspended in 200 ,ul of 50 mM NaCl and 1 mM HEPES (pH 7.1) and was used as a crude sarcoplasmic reticulum preparation. The yield was approximately 500 ,ug crude sarcoplasmic reticulum protein/g heart tissue. The protein concentration of crude muscle homogenate and crude sarcoplasmic reticulum was measured by a modified biuret reaction using bicinchoninic acid (micro BCA protein assay kit, Pierce Chemical Co., Rockford, Il1.).46
Protein Gel Electrophoresis and Western Blot Analysis SDS-polyacrylamide gel electrophoresis was performed with a slab gel apparatus according to the procedure of Laemmli.47 Acrylamide gel of 13.5% (0.75-mm thickness) was used for the separation of sarcoplasmic reticulum proteins, and 11% gel was used for the analysis of crude muscle homogenate. Ten and five micrograms of sarcoplasmic reticulum protein and muscle homogenate protein were separated by electrophoresis. MHC and actin bands were identified on the basis of their abundance and mobility compared with molecular weight markers. A strong band corresponding to albumin was used as an internal standard to quantitate the total amount of myosin and actin.
To analyze the amount of Ca'+-ATPase, proteins in the gel were transferred electrophoretically to a nitrocellulose membrane at 150 mA for 2 hours in a buffer containing 40 mM Tris (pH 8.5), 0.25 M glycine, 0.1% SDS, and 20% ethanol.48 After blotting, the molecular weight marker lane was cut out and stained with 1% amido black, and sample lanes were processed for immunoreaction. After blocking with 3% bovine serum albumin in 0.03% Tween 20/phosphate buffered saline, the membrane was incubated with a polyclonal antirabbit Ca'+-ATPase antibody for 2 hours. Then, the membrane was rinsed, reacted with '1M-labeled protein 
Statistical Analyses
Overall differences within groups were determined by the Kruskal-Wallis test, which is equivalent to an analysis of variance of the ranks.49,50 When this test indicated that differences existed, individual experimental groups were compared with the control group using the Wilcoxon U test. The test was considered significant at p<0.05.
Results

Effect of Thyroid Hormone on Atrial and Ventricular Weight
Atrial and ventricular weight, both as raw values and values normalized for body weight, were increased significantly in the groups that were injected with T4 for 4 days (T4-4-day group) and 8 days (T4-8-day group) but decreased in the group in which PTU was administered for 4 weeks (PTU group) ( Table 1) . The blood T4 level in the PTU group was measured using a standard clinical radioimmunoassay kit. Blood T4 level fell from 2.7 ,g/dl (average titer before PTU treatment) to < 1.0 ,ug/dl after 4 weeks of PTU treatment, indicating the development of hypothyroidism in the rabbits. These data indicate the development of cardiac hypertrophy in thyrotoxic heart and cardiac atrophy in hypothyroid heart. (Figure 2) .
The expression level of the mRNA for sarcoplasmic reticulum Ca2+-ATPase was also examined in these heart preparations ( Figure 1B) . The cardiac/slowtwitch muscle Ca2'-ATPase mRNA level was increased in hyperthyroid ventricle (T4-4-day group: 174%, p<0.05; T4-8-day group: 186%, p<0.05) and decreased to 75% in hypothyroid ventricle (PTU group: p<O.OS) (Figure 2 ). In the atrium, the cardiac/slowtwitch muscle Ca2+-ATPase mRNA was also increased to 128% (T4-4-day group: p<0.05) and to 133% (T4-8-day group: p<0.05) and decreased to 58% in hypothyroidism (PTU group: p<0.05) ( Figure 2 ).
In addition to the Ca2+-ATPase, the mRNA levels of phospholamban were examined using Northern blots ( Figure 1B) . In thyrotoxic ventricle, the phospholamban mRNA level was decreased (T4-8-day group: 72%,p<0.05) as opposed to an increased level of Ca2+-ATPase mRNA (Figure 2 ). In PTU-treated hypothyroid ventricle, the phospholamban mRNA level was decreased (77%, p<0.05) as noted for Ca2+-ATPase mRNA. The phospholamban mRNA level was similarly decreased in the atrial muscle of hyperthyroid rabbits (T4-4-day group: 85%,p<0.05; T4-8-day group: 64%, p<0.05), but in hypothyroid rabbit atrium, the relative level of phospholamban mRNA did not change (PTU group: 96%, p=NS) ( Figure 2 Figure 4B ). The mean ratio in the control group was defined as 100%, and ratio in the experimental groups was expressed as the percentage of change compared with values obtained from the control group. As shown in Figure 4B, To examine whether the calcium release process in skeletal muscle is also regulated by thyroid hormone levels, we have analyzed the mRNA level of skeletal muscle ryanodine receptor in soleus and plantaris muscle from the same rabbits used for the analysis of cardiac muscle ( Figure 5 ). It is of note that both slowand fast-twitch skeletal muscle tissues express only the skeletal muscle specific ryanodine receptor isoform. 23 In hyperthyroid rabbits, the relative level of skeletal muscle ryanodine receptor mRNA was increased .z8 4 Uah- in soleus muscle (T4-4-day group: 140%, p<0.05; T4-8-day group: 128%, p<0.05) and in plantaris muscle (T4-4-day group: 135%, p<0.05; T4-8-day group: 135%, p<0.05) ( Figure 5 ). In hypothyroidism the expression level of skeletal muscle ryanodine receptor mRNA was not changed.
Thyroid Hormone Increased the Expression of Ca2+-ATPase mRNA in Skeletal Muscles
To understand whether the thyroid hormone has a similar effect on the Ca2+-ATPase mRNA levels of skeletal muscle, we quantitated the Ca2+-ATPase mRNA levels in soleus and plantaris muscle using Northern blot analysis ( Figure 6 ). Adult skeletal muscle expresses two different Ca2+-ATPases: 1) the cardiac/slow-twitch muscle isoform (SERCA2) and 2) the fast-twitch muscle isoform (SERCA1). These Ca2'-ATPases can be identified on Northern blot analysis, since their mRNAs are of different sizes.
In soleus muscle the level of cardiac/slow-twitch Ca2+-ATPase mRNA was increased in hyperthyroidism (T4-4-day group: 187%, p<0.05; T4-8-day group: 143%, p<0.05) but decreased in hypothyroidism (PTU group: 75%, p<0.05) ( Figure 6A ). In addition to an increase in the cardiac/slow-twitch Ca2+-ATPase mRNA isoform, the fast skeletal iso- Percentage of fast-twitch (% FAST) Ca2+-ATPase in control, hyperthyroid, and hypothyroid plantaris muscle was estimated (fastlfast+slow).
form (not detectable in euthyroid soleus muscle) was induced after T4 treatment (data not shown). Plantaris muscle expresses both the fast-twitch isoform and the cardiac/slow-twitch isoform. In hyperthyroid rabbits, the two isoforms were positively upregulated in this muscle (fast-twitch isoform for T4-4-day group: 201%, p<0.05; fast-twitch isoform for T4-8-day group: 239%, p<0.05; cardiac/slowtwitch isoform for T4-4-day group: 164%, p<0.05; cardiac/slow-twitch isoform for T4-8-day group: 169%, p<0.05), whereas in hypothyroid rabbits, the mRNA for the two Ca2+-ATPase isoforms did not change (fast-twitch isoform for PTU group: 92%, p=NS; cardiac/slow-twitch isoform for PTU group: 106%,p=NS) ( Figure 6A ). The magnitude of induction of Ca2+-ATPase mRNA in hyperthyroidism was greater for the fast-twitch isoform than for the cardiac/slow-twitch isoform. The relative proportion of fast-twitch isoform mRNA (fast/fast+slow) was increased from 48% (control) to 55% in the T4-4-day group (p<0.05) and to 57% in the T4-8-day group (p<0.05) but decreased to 42% in the PTU group (p<0.05) ( Figure 6B ). We also examined the expression levels of phospholamban and calsequestrin mRNA in soleus muscle. In skeletal muscle, phospholamban is expressed only in slow-twitch muscle (soleus muscle) but not in fast-twitch muscle (plantaris muscle). In soleus muscle, the phospholamban mRNA level was reduced to 43% in hyperthyroidism (T4-4-day group: p<0.05) (Figure 7 ).
Two types of calsequestrin, the cardiac/slow-twitch isoform and the fast-twitch isoform, are expressed in soleus muscle. As shown in Figure 7, The demonstration that thyroid hormone affects sarcoplasmic reticulum protein expression in skeletal muscle in the same manner as observed for the heart is unexpected. The thyroid hormone effects on skeletal muscle are primarily hormonal, whereas for cardiac muscle there is a humoral as well as a secondary hemodynamic effect, resulting from the elevated metabolic rate associated with hyperthyroidism.52 Nevertheless, the ryanodine receptor, Ca2-ATPase, phospholamban, and calsequestrin mRNA levels changed to similar extents in both skeletal and cardiac muscle. These results would suggest that the thyroid hormone effect on the expression level of sarcoplasmic reticulum proteins in the heart is likely to be direct rather than secondary.
The Modulation of Sarcoplasmic Reticulum Protein Expression Plays an Important Role in the Altered Functional State of Muscle Induced by Thyroid Hormone Stress Both the sarcoplasmic reticulum and the contractile protein myosin play a major role in controlling muscle contractile properties in response to stress. It is well known that the MHC isozyme pattern in each muscle varies widely to meet diverse functional requirements, even in the euthyroid state.53-55 For example, fast-twitch skeletal muscle expresses the high ATPase activity MHC isoforms predominantly (fast IIA and fast IIB isoforms), and hyperthyroidism changes the composition of two isoforms whose ATPase activities are both high.53,5456 Nevertheless, T4 treatment does cause a further increase in the velocity of contraction and relaxation in fast-twitch muscle.56 These changes in contractile properties are unlikely to result from MHC fiber-type changes since the thyroid hormone effect on MHC is the interconversion between two types of fast fibers (from fast IIA to fast IIB). In the absence of a significant change in myosin ATPase activity, alterations in the rate of calcium release and uptake by sarcoplasmic reticulum could contribute significantly to accelerated mechanical properties in hyperthyroidism. In this study, we have demonstrated that the ryanodine receptor mRNA and sarcoplasmic reticulum Ca2+-ATPase mRNA were both increased in fast-twitch muscle (plantaris muscle) in hyperthyroidism, supporting this hypothesis.
In addition to fast-twitch muscle, we also observed an increase in the expression of both cardiac ryanodine receptor and cardiac Ca2'-ATPase mRNA in atrium, a muscle tissue expressing exclusively the fast type of myosin in euthyroidism and hyperthyroidism. 57 Our data suggest that hyperthyroidism can further increase the contractile velocity of atrial muscle by accelerating calcium release and uptake.
In summary, we offer the following conclusions: 1) The thyroid hormone-induced changes in the levels of mRNAs encoding Ca2' pump and Ca2+ release channel proteins are coordinately regulated in both cardiac and skeletal muscle.
2) The increased expression of the Ca2' release channel mRNA and Ca2+-ATPase mRNA should lead to an increase in corresponding proteins and thus to an increased calcium release and reuptake capacity in hyperthyroidism. Hypothyroidism should produce the opposite changes.
3) The expression of mRNA for calsequestrin is not altered by thyroid hormone, indicating that there is likely to be little effect of the hormone on the calcium storage capacity. 4) Thyroid hormoneinduced changes in the level of mRNA for sarcoplasmic reticulum proteins appear to be a result of the direct action of thyroid hormone on the muscle and not of hemodynamic overload, since parallel results were obtained in both cardiac and skeletal muscle. 5) The calcium regulatory capacity of sarcoplasmic reticulum plays an important role in altering muscle properties in the absence of a significant change of myosin ATPase activity.
